Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features of patients with MTAP-deleted bladder cancer.
De Souza AL, Mega AE, Douglass J, Olszewski AJ, Gamsiz Uzun ED, Uzun A, Chou C, Duan F, Wang J, Ali A, Golijanin DJ, Holder SL, Lagos GG, Safran H, El-Deiry WS, Carneiro BA. De Souza AL, et al. Among authors: safran h. Am J Cancer Res. 2023 Jan 15;13(1):326-339. eCollection 2023. Am J Cancer Res. 2023. PMID: 36777505 Free PMC article.
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
Crane CH, Winter K, Regine WF, Safran H, Rich TA, Curran W, Wolff RA, Willett CG. Crane CH, et al. Among authors: safran h. J Clin Oncol. 2009 Sep 1;27(25):4096-102. doi: 10.1200/JCO.2009.21.8529. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636002 Free PMC article. Clinical Trial.
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704.
Bitterman DS, Winter KA, Hong TS, Fuchs CS, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB 3rd, Kasunic T, Mulcahy M, Strauss JF, DiPetrillo T, Stella PJ, Chen Y, Plastaras JP, Crane CH. Bitterman DS, et al. Among authors: safran h. Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):201-211. doi: 10.1016/j.ijrobp.2020.08.042. Epub 2020 Aug 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 32858111 Free PMC article. Clinical Trial.
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
Willett CG, Safran H, Abrams RA, Regine WF, Rich TA; Gastrointestinal Committee of the Radiation Therapy Oncology Group. Willett CG, et al. Among authors: safran h. Int J Radiat Oncol Biol Phys. 2003;56(4 Suppl):31-7. doi: 10.1016/s0360-3016(03)00446-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12826249 Review.
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.
Van Cutsem E, van de Velde H, Karasek P, Oettle H, Vervenne WL, Szawlowski A, Schoffski P, Post S, Verslype C, Neumann H, Safran H, Humblet Y, Perez Ruixo J, Ma Y, Von Hoff D. Van Cutsem E, et al. Among authors: safran h. J Clin Oncol. 2004 Apr 15;22(8):1430-8. doi: 10.1200/JCO.2004.10.112. J Clin Oncol. 2004. PMID: 15084616 Clinical Trial.
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Crane CH, et al. Among authors: safran h. J Clin Oncol. 2011 Aug 1;29(22):3037-43. doi: 10.1200/JCO.2010.33.8038. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709185 Free PMC article. Clinical Trial.
168 results